Onegene Biotechnology

South Korea
Seongnam-si, Gyeonggi-do, South Korea

Company profile

Onegene Biotechnology company profile

Onegene Biotechnology is a biotechnology company that develops highly potent tri- or intraspecific protein-based drugs. It allows an unlimited combination of different types of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties opens new design space for multispecific protein drugs with CMC feasibility.

Business identity

Phone number
031-8014-2842
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2016-01-01, Year

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$12.7M
Last funding
Series Unknown / 2022-05-01
Last equity funding
Series Unknown
Investors
10

Founders and investors

Investors

KB SecuritiesPremier PartnersQuantum Ventures KoreaSTIC VenturesTIPS Program